ECL vs JANX · P/E 35, rev $8.48B vs rev $10.3M
Ecolab Inc (ECL) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. JANX currently screens at market cap $1.49B.
Not investment advice. Open the ECL and JANX stock pages for the full models.
Not investment advice.